Search Results 681-690 of 16828 for GLP-1 agonists

  1. Neurology - Clinical trials

    This is a peripheral blood Collection Protocol to study the T-cell immune responses of patients with malignancies displaying one of three different patterns ...

  2. Hematology - Clinical trials

    Patients will be randomized 1:1 into the two arms. ... Avelumab In Combination Regimens That Include An Immune Agonist ... And I think that is one of the ...

  3. Gemcitabine, Cisplatin, and Abraxane in Advanced Biliary Cancers - Mayo Clinic

    ... 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market. Study IDs. Site IRB.

  4. Enzalutamide for Patients With Androgen Receptor Positive Salivary Cancers - Mayo Clinic

    Researchers hope to learn if the study drug will shrink the cancer by at least 30% compared to its present size, in at least 1 out of 5 patients.

  5. Neuroendocrine tumors - Doctors and departments - Mayo Clinic

    Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...

  6. Neuroendocrine tumors - Doctors and departments - Mayo Clinic

    Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...

  7. Polycystic ovary syndrome (PCOS) - Doctors and departments - Mayo Clinic

    Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...

  8. Gastroesophageal reflux disease (GERD) - Doctors and departments - Mayo Clinic

    Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...

  9. Metastatic castration-resistant prostate cancer (mCRPC) - Diagnosis and treatment - Mayo Clinic

    These medicines are called luteinizing hormone-releasing hormone (LHRH) agonists and antagonists. ... If one stops working, your healthcare team might try other ...

  10. Phase 2 Study of Ipilimumab in Children and Adolescents (12 to < 18 Years) With Previously Treated or Untreated, Unresectable Stage III or Stage lV Malignant Melanoma - Mayo Clinic

    ... 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new ... 1 (PD-L1) or CD137 agonists; Symptomatic brain metastases; History of ...